In a cluster-randomised trial across 60 Ethiopian woredas, neither a flexible open-vial policy nor a switch to 5-dose measles vaccine vials changed first-dose coverage versus control; the 5-dose switch raised timely first doses (ARD 18%) and second-dose coverage (ARD 17%).
RCTn = 60 woredas
Wallace et al. Ethiopia missed opportunities for vaccination study: Cluster-randomized evaluation of 5-dose measles vaccine vials and a flexible open-vial policy, 2021-2022